Drug distribution between blood and brain as a determinant of antipsychotic drug effects.

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Biological Psychiatry

• Publication date

  1992-11-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/0006-3223(92)90085-EPMID 1360262
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A fixed dose study of the plasma concentration and clinical effects of thioridazine and its major metabolites

  2004cited by this paper
• HPLC with electrochemical detection to measure chlorpromazine, thioridazine and metabolites in human brain

  2004cited by this paper
• D1- and D2-dopamine receptor occupancy during treatment with conventional and atypical neuroleptics

  2004cited by this paper
• Cloning of the gene for a human dopamine D5 receptor with higher affinity for dopamine than D1

  1991cited by this paper
• Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine

  1991cited by this paper
• Detection of psychoactive drugs in vivo in humans using 19F NMR spectroscopy.

  1991cited by this paper
• High central D2-dopamine receptor occupancy as assessed with positron emission tomography in medicated but therapy-resistant schizophrenic patients.

  1991cited by this paper
• Advances in Schizophrenia Research

  1990cited by this paper
• Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics

  1990cited by this paper
• PET imaging of dopamine receptors in human basal ganglia: relevance to mental illness.

  1990cited by this paper
• Central D2-dopamine receptor occupancy in schizophrenic patients treated with antipsychotic drugs.

  1988cited by this paper
• Significance of neuroleptic dose and plasma level in the pharmacological treatment of psychoses.

  1988cited by this paper
• 19F magnetic resonance imaging and spectroscopy of a fluorinated neuroleptic ligand: in vivo and in vitro studies.

  1988cited by this paper
• Persistence of haloperidol in the brain.

  1988cited by this paper
• Astemizole: A Long-Acting, Nonsedating Antihistamine

  1987cited by this paper
• Blood to brain distribution of neuroleptics.

  1987influential reference
• Pharmaco-epidemiology in 136 hospitalized schizophrenic patients.

  1987cited by this paper
• Goodman and Gilman's the Pharmacological Basis of Therapeutics

  1986cited by this paper
• In vivo potencies of antipsychotic drugs in blocking alpha 1 noradrenergic and dopamine D2 receptors: implications for drug mechanisms of action.

  1986cited by this paper
• Fluorinated psychopharmacological agents: noninvasive observation by fluorine-19 nuclear magnetic resonance.

  1986cited by this paper
• Assay of plasma thioridazine and metabolites by high-performance liquid chromatography with amperometric detection.

  1984cited by this paper
• Antagonism by neuroleptics of neurotransmitter receptors of normal human brain in vitro.

  1984cited by this paper
• Dissimilar dosing with high-potency and low-potency neuroleptics.

  1984cited by this paper
• Cohort analysis of suicide rates in Australia.

  1983cited by this paper
• Simultaneous determination of haloperidol and its reduced metabolite in serum and plasma by isocratic liquid chromatography with electrochemical detection.

  1983cited by this paper
• Clinical use of the radioreceptor assay for neuroleptics.

  1980cited by this paper
• Relationship of neuroleptic drug effects at brain dopamine, serotonin, alpha-adrenergic, and histamine receptors to clinical potency.

  1980cited by this paper
• Domperidone, a specific in vitro dopamine antagonist, devoid of in vivo central dopaminergic activity.

  1979cited by this paper
• Neuroleptic, antimuscarinic, and antiadrenergic activity of chlorpromazine, thioridazine, and their metabolites.

  1979cited by this paper
• Brain distribution and kinetics of 11C-chlorpromazine in schizophrenics: positron emission tomography studies.

  1979cited by this paper
• Anti-schizophrenic drugs--membrane receptor sites of action.

  1977cited by this paper
• The Pharmacological Basis of Therapeutics

  1976cited by this paper
• Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs.

  1976cited by this paper
• Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs

  1976cited by this paper
• Brain receptors for antipsychotic drugs and dopamine: direct binding assays.

  1975cited by this paper
• Diagnosis and Drug Treatment of Psychiatric Disorders

  1969cited by this paper
• Chlorpromazine in the treatment of neuropsychiatric disorders.

  1954cited by this paper

• Haloperidol, Olanzapine, and Risperidone Induce Morphological Changes in an In Vitro Model of Human Hippocampal Neurogenesis

  2024cites this paper
• Long covid, neuropsychiatric disorders, psychotropics, present and future.

  2022cites this paper
• Assessment of Brain-To-Blood Drug Distribution Using Liquid Chromatography.

  2021cites this paper
• The Effectiveness of Chlorpromazine to Decrease the Level of Tumor Necrosis Factor-Alpha Serum in Schizophrenic Patients with Coronavirus Disease 2019

  2021cites this paper
• Pharmacotherapy of schizophrenia: Mechanisms of antipsychotic accumulation, therapeutic action and failure.

  2021cites this paper
• Repurposing chlorpromazine to treat COVID-19: The reCoVery study

  2020cites this paper
• Repositionnement de la chlorpromazine dans le traitement du COVID-19 : étude reCoVery./ [Repurposing of chlorpromazine in COVID-19 treatment: the reCoVery study].

  2020cites this paper
• Repositionnement de la chlorpromazine dans le traitement du COVID-19 : étude reCoVery

  2020cites this paper
• Psychosis Treatment During COVID-19 Pandemic and the Potential Role of Phenothiazines: A Call for Research Studies.

  2020cites this paper
• Repositionnement de la chlorpromazine dans le traitement du COVID-19 : étude reCoVery

  2020cites this paper
• Dopamine, the antipsychotic molecule: A perspective on mechanisms underlying antipsychotic response variability

  2018cites this paper
• Effects of the antipsychotics haloperidol, clozapine, and aripiprazole on the dendritic spine.

  2018cites this paper
• Different influence of antipsychotics on the balance between pro‐ and anti‐inflammatory cytokines depends on glia activation: An in vitro study

  2017cites this paper
• Revisiting co-trimoxazole for the treatment of tuberculosis

  2016cites this paper
• Modeling of Malignant Glioma and Investigations into Novel Treatments

  2015influential citation
• Blockade of voltage-gated K⁺ currents in rat mesenteric arterial smooth muscle cells by MK801.

  2015cites this paper
• In vitro screening of clinical drugs identifies sensitizers of oncolytic viral therapy in glioblastoma stem-like cells

  2015cites this paper
• Pharmacological inhibition of MALT1 protease activity protects mice in a mouse model of multiple sclerosis

  2014cites this paper
• Molecular and cellular pharmacology Antipsychotics , chlorpromazine and haloperidol inhibit voltage-gated proton currents in BV 2 microglial cells

  2014influential citation
• Chlorpromazine confers neuroprotection against brain ischemia by activating BKCa channel.

  2014cites this paper
• Drug elucidation: invertebrate genetics sheds new light on the molecular targets of CNS drugs

  2014cites this paper
• Clozapine-induced paroxysmal discharges

  2013cites this paper
• Potential antimicrobial agents for the treatment of multidrug-resistant tuberculosis

  2013cites this paper
• Use-dependent inhibition of synaptic transmission by the secretion of intravesicularly accumulated antipsychotic drugs.

  2012cites this paper
• Effects of phenothiazine-class antipsychotics on the function of α7-nicotinic acetylcholine receptors.

  2011cites this paper
• Effects of diverse psychopharmacological substances on the activity of brain prolyl oligopeptidase.

  2011cites this paper
• Effects of quetiapine, risperidone, 9-hydroxyrisperidone and ziprasidone on the survival of human neuronal and immune cells in vitro

  2010cites this paper
• Effects of amphetamine on salivary secretion.

  2009cites this paper
• Using pharmacokinetic-pharmacodynamic modelling as a tool for prediction of therapeutic effective plasma levels of antipsychotics.

  2008influential citation
• Metabolism-Induced Toxicity of Selegiline and Carbamazepine Studied with an In Vitro Method

  2008cites this paper
• Sensitive liquid chromatography/tandem mass spectrometry method for the determination of the lipophilic antipsychotic drug chlorpromazine in rat plasma and brain tissue.

  2007cites this paper
• Antipsychotics inhibit TREK but not TRAAK channels.

  2007cites this paper
• Atypical Antipsychotic Drugs Directly Impair Insulin Action in Adipocytes: Effects on Glucose Transport, Lipogenesis, and Antilipolysis

  2007cites this paper
• Effects of haloperidol, clozapine and olanzapine on the survival of human neuronal and immune cells in vitro

  2007cites this paper
• Brain distribution of selected antipsychotics in schizophrenia.

  2006cites this paper
• The combined use of human neural and liver cell lines and mouse hepatocytes improves the predictability of the neurotoxicity of selected drugs.

  2006cites this paper
• Neuroleptic drugs in the human brain

  2006cites this paper
• Neuroleptic drugs in the human brain: clinical impact of persistence and region-specific distribution.

  2006cites this paper
• Suppression of cortical spreading depression in migraine prophylaxis

  2006cites this paper
• Plasma clozapine levels and clinical response in treatment-refractory Chinese schizophrenic patients.

  2006cites this paper
• Inhibition of the cloned delayed rectifier K+ channels, Kv1.5 and Kv3.1, by riluzole.

  2005cites this paper
• Concentrations of remoxipride and its phenolic metabolites in rat brain and plasma. Relationship to extrapyramidal side effects and atypical antipsychotic profile

  2005cites this paper
• A recursive-partitioning model for blood–brain barrier permeation

  2005cites this paper
• Antipsychotic drugs antagonize human serotonin type 3 receptor currents in a noncompetitive manner

  2004cites this paper
• Modulation of glucose uptake in glial and neuronal cell lines by selected neurological drugs.

  2004cites this paper
• Flupentixol and trifluperidol reduce interleukin-1 beta and interleukin-2 release by rat mixed glial and microglial cell cultures.

  2004cites this paper
• Effects of typical and atypical antipsychotics on human glycine transporters.

  2004cites this paper
• A Mathematical Model for Prediction of Drug Molecule Diffusion Across the Blood-Brain Barrier

  2004cites this paper
• Chlorpromazine and loxapine reduce interleukin-1beta and interleukin-2 release by rat mixed glial and microglial cell cultures.

  2004cites this paper
• Effects of clozapine, haloperidol and iloperidone on neurotransmission and synaptic plasticity in prefrontal cortex and their accumulation in brain tissue: an in vitro study.

  2003cites this paper
• Flupentixol and trifluperidol reduce secretion of tumor necrosis factor-alpha and nitric oxide by rat microglial cells.

  2003cites this paper
• Differential acute effects of fluoxetine on frontal and auditory cortex networks in vitro.

  2003cites this paper
• Mechanisms of cellular distribution of psychotropic drugs. Significance for drug action and interactions.

  2003cites this paper
• Brain, plasma and tissue pharmacokinetics of risperidone and 9-hydroxyrisperidone after separate oral administration to rats

  2002cites this paper
• Neuronal Network Analyses in vitro of Acute Individual and Combined Responses to Fluoxetine and Ethanol

  2002cites this paper
• Duloxetine, 60 mg once daily, for major depressive disorder: a randomized double-blind placebo-controlled trial.

  2002cites this paper
• Thioridazine-fluoxetine interaction at the level of the distribution process in vivo.

  2002cites this paper
• Antipsychotic drugs: importance of dopamine receptors for mechanisms of therapeutic actions and side effects.

  2001cites this paper
• Distribution of the methylpiperazinopyridobenzoxazepine derivative JL13, a potential antipsychotic, in rat brain

  2001cites this paper
• Neuroimaging and Drug Development: An Algorithm for Decision Making

  2001cites this paper
• Inhibition of human alpha1E subunit-mediated ca2+ channels by the antipsychotic agent chlorpromazine.

  2001cites this paper
• Inhibition of glucose transport in PC12 cells by the atypical antipsychotic drugs risperidone and clozapine, and structural analogs of clozapine.

  2001cites this paper
• Neuroimaging and Drug Development: An Algorithm for Decision Making

  2001cites this paper
• Correlation and prediction of a large blood-brain distribution data set--an LFER study.

  2001cites this paper
• The Role of Neuroimaging in Development of and Treatment With Antipsychotics

  2001cites this paper
• Kann der pharmakologisch aktive N-demethylierte Metabolit von Clozapin die Blut-Hirn-Schranke durchdringen?

  2001cites this paper
• Steady state concentrations of clomipramine and its major metabolite desmethylclomipramine in rat brain and serum after oral administration of clomipramine.

  2000cites this paper
• A priori prediction of tissue:plasma partition coefficients of drugs to facilitate the use of physiologically-based pharmacokinetic models in drug discovery.

  2000cites this paper
• Chlorpromazine induces apoptosis in activated human lymphoblasts: a mechanism supporting the induction of drug-induced lupus erythematosus?

  2000cites this paper
• The role of lysosomes in the cellular distribution of thioridazine and potential drug interactions.

  1999cites this paper
• Persistence of haloperidol in human brain tissue.

  1999cites this paper
• Inhibition by fluoxetine of voltage-activated ion channels in rat PC12 cells.

  1999cites this paper
• Pharmacokinetics and tissue distribution of olanzapine in rats

  1999cites this paper
• Distribution after repeated oral administration of different dose levels of risperidone and 9-hydroxy-risperidone in the brain and other tissues of rat

  1998influential citation
• Pharmacokinetics of thioridazine and its metabolites in blood plasma and the brain of rats after acute and chronic treatment.

  1997cites this paper
• Relationship between immobilised artificial membrane chromatographic retention and the brain penetration of structurally diverse drugs.

  1997cites this paper
• Inhibition of β‐Amyloid Formation by Haloperidol: A Possible Mechanism for Reduced Frequency of Alzheimer's Disease Pathology in Schizophrenia

  1997cites this paper
• A method to estimate in vivo D2 receptor occupancy by antipsychotic drugs.

  1996cites this paper
• Visualization of Antipsychotic Drug Binding to Living Mesolimbic Neurons Reveals D2 Receptor, Acidotropic, and Lipophilic Components

  1995cites this paper
• Distribution of Fluphenazine and Its Metabolites in Brain Regions and Other Tissues of the Rat

  1995cites this paper
• Thioridazine enantiomers in human tissues.

  1994cites this paper
• Tissue Concentrations of Clozapine and its Metabolites in the Rat

  1993cites this paper